Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Pharma in Focus Jobs
Latest News
Pfizer MD encourages risk taking
Workplace: Pfizer MD Melissa McGregor has told attendees at a Women in Life Sciences event that courage and risk taking are key to workplace success.
Gilead's extraordinary PBS year
Reimbursement: With stats now available for a full 12 months since Gilead's blockbusting hep C drugs were listed, we assess one of the most remarkable rises in PBS history.
TGA scheduling predicts new arrivals
Pipeline: The TGA has scheduled a number of medicines in advance of their anticipated appearance on the ARTG.
Hunt misled patients on vax: Labor
Medicines Supply: Labor's Catherine King says Health Minister Greg Hunt misled parents about availability of GSK's meningococcal B vaccine Bexsero in the wake of a national shortage.
Aussies make world-first malaria vaccine
Pipeline: Australian researchers are a step closer to the world's first malaria vaccine after initial human trials proved successful in creating an immune response to multiple parasite proteins.
Most Popular
Hunt makes the most of April PBS
Reimbursement: Health Minister Greg Hunt has used PBS price cuts and new listings due on 1 April to heavily promote the government's health savings - and spending - credentials.
Pfizer denied in Brenzys court case
Patent Litigation: An attempt by Pfizer to set up a patent infringement case against MSD's Enbrel competitor, Brenzys - set to PBS list on 1 April - has been knocked back by the Federal Court.
Patient groups rate pharma
Reputation: Australian patient groups have rated pharmacos low for innovation compared to groups in other countries but not as low as NZ, while ViiV and AbbVie have topped the most reputable list.
TGA bows to industry on fast tracking
Sansom Reforms: The TGA has made changes to its expedited pathways proposal on the back of feedback from industry.
Paradigm shift in RA outcomes
Treatment Trends: New products and refined treatment regimens mean RA patients - who cost the PBS $600m a year - can soon expect to lead normal lives says the MJA.
Teva confirms layoffs, disputes number
Companies: Israeli media reports that up to 6000 jobs worldwide may go are 'inaccurate' says Teva, while confirming an efficiency program and staffing freeze.
GSK hit by another vax shortage
Medicines Access: As states rush to vaccinate teenagers against meningococcal W, surging demand has led to a short-term shortage of GSK's Menveo.
Govts respond to industry concern on clinical trials
Clinical Trials: State and federal governments have responded to industry concern around the progress of clinical trials reform with a 'revitalised agenda' that includes 'central coordinating units'.
Millions of adults don't vaccinate
Immunisation: Close to four million Australian adults are missing out on free vacinnations each year, risking serious disease, says research marking the launch of the University of NSW Vaccine and Infection Research Lab.
Pharmas flock to innovation fair
Innovation: Major pharmacos headquartered in the Sydney electorate of Bennelong will join an 'Innovation Fair' to be held in Parliament House tonight.
Approvals Action
Baxalta registers new haemophilia treatment
Shire-owned Baxalta has won TGA approval for a new haemophilia A treatment under the brand name Adynovate.
Pipeline Monitor
First Parkinson's drug in a decade wins US tick
Parkinson's disease patients now have something to turn to in the 'off' period when their standard medication loses effectiveness.
Debating Point
Resources in question as TGA modernises
Most areas of the pharmaceutical sector appear to agree that modernising the TGA is a good thing but how much pressure the new requirements will place on the regulator's resources remains an issue.
FREE Content
Events & Conferences
Pharma in Focus Jobs